Company Name or Ticker Symbol
Search for other Categories
Amgen Inc.  (AMGN)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
Price: $196.1200 $0.51 0.261%
Day's High: $ 196.96 Week Perf: -0.04 %
Day's Low: $ 194.89 30 Day Perf: 0.64 %
Volume (M): 252 52 Wk High: $ 201.23
Volume (M$): $ 49,353 52 Wk Avg: $ 180.90
Open: 195.94 52 Wk Low: 163.31
You need to upgrade your Flash Player

 Market Capitalization (Millions $) 129,439
 Shares Outstanding (Millions) 660
 Employees 17,900
 Revenues (TTM) (Millions $) 23,188
 Net Income (TTM) (Millions $) 2,364
 Cash Flow (TTM) (Millions $) 7,502
 Capital Exp. (TTM) (Millions $) 653
Amgen Inc.
Amgen Inc. Is a global biotechnology company that discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology. On July 15, 2002, Amgen acquired all of the outstanding common stock of Immunex Corporation (“Immunex”) for stock and cash valued at $17.8 billion in a transaction accounted for as a business combination. Immunex was a leading biotechnology company dedicated to developing immune system science to protect human health. The acquisition has enhanced Amgen’s strategic position within the biotechnology industry by strengthening and diversifying its (1) product base and product pipeline in key therapeutic areas, and (2) discovery research capabilities in proteins and antibodies.

AMGN is expected to report next financial results on October 25, 2018.

Amgen's Segments
United States
 Segment    80.22 % of total Revenue
 Segment    19.78 % of total Revenue
 Segment    17.73 % of total Revenue
 Segment    8.94 % of total Revenue
 Segment    11.6 % of total Revenue
 Segment    5.15 % of total Revenue
 Segment    2.48 % of total Revenue
 Segment    42.11 % of total Revenue
 Segment    6.85 % of total Revenue
 Segment    26.45 % of total Revenue
 Segment    0.98 % of total Revenue
  Company Estimates  
  Revenue Outlook
Amgen announced annual revenue outlook on Oct. 28, 2015

Earnings Outlook
Amgen Inc. issued annual earnings guidance on Oct. 28, 2015

Geographic Revenue Dispersion
United States 76.74 %
International 23.26 %

J2 Global, Inc.

J2 Global, Inc announced second quarter operating profit of $54.383 millions

J2 Global, Inc delivered mixed results in the second quarter, where Sales grew by 5.39 % to $287.89 millions in comparison to $273.17 millions on a year-over-year basis, while earnings decreased by -9.52 % to $0.57 per share, as comparison at $0.63 in the prior year quarter.

Everest Re Group Ltd

EPS $1.7, Sales more than Double

In the second quarter Everest Re Group Ltd eps of $1.70 per share compare to $0.00 a year ago and eps dropped by -66.73 % from $5.11 per share from the previous quarter.

Sales increased sharply by 312.89 % to $1.89 billions from $458.46 millions in the same quarter a year ago and sequentially Sales surged by 80.14 % from $1.05 billions.

Utah Medical Products Inc

Sales and Profits Increased

Utah Medical Products Inc reported moderate Sales growth of 1.26 % to $10.97 millions in the second quarter, eps grew by 10.58 % to $1.15 year on year.

Northern Oil & Gas, Inc.

Northern Oil & Gas, Inc announced second quarter operating profit of $16.317867 millions

Northern Oil & Gas, Inc announced earnings per share of $-0.49 and Sales of $66.61 millions in the second quarter, Company's slipped into loss per share, versus $0.27 eps, earned in the same quarter a year ago, although Northern Oil & Gas, Inc saw it's Sales rise by 1.56 % in the same period.

Neos Therapeutics, Inc.

Neos Therapeutics, Inc announced second quarter operating shortfall of $-13.267 millions

Neos Therapeutics, Inc announced very strong Sales growth of 131.47 % year on year to $11.36 millions in the second quarter, but lost money at $-0.52.

AMGN's Valuation Current
Price to Earnings PE Ratio (TTM) 53.99
Price to Earnings PE Ratio (Expected) 22.90
Price to Sales (TTM) 5.58
Price to Sales (Expected) 5.88
Price to Book 8.68
AMGN's Financial Strength Current
Quick Ratio 2.62
Working Capital Ratio 3.39
Leverage Ratio (MRQ) 3.54
Total Debt to Equity 2.31
Interest Coverage (TTM) -
Debt Coverage (TTM) 0.29
Per Share Current
Earnings (TTM) 3.63 $
Revenues (TTM) 35.13 $
Cash Flow (TTM) 11.37 $
Cash 44.54 $
Book Value 22.59 $
Dividend (TTM) 4.94 $

• View Valuation Comparisons • View Growth Rates Comparisons

You need to upgrade your Flash Player
AMGN's Efficiency Current
Revenue per Employee (TTM) 1,295,419
Net Income per Employee (TTM) 132,067
Receivable Turnover Ratio (TTM) 6.73
Inventory Turnover Ratio (TTM) 1.36
Asset Turnover Ratio (TTM) 0.31
AMGN's Profitability Ratio Current
Gross Margin 83.1 %
Operating Margin 46.74 %
Net Margin 37.89 %
Net Cash Flow Margin 6.44 %
Effective Tax Rate (TTM) 76.03 %
Management Effectiveness Current
Return On Assets (TTM) 3.16 %
Return On Investment (TTM) 3.63 %
Return On Equity (TTM) 10.75 %
Dividend Yield 2.69 %
Payout Ratio (TTM) 135.98 %
• View Efficiency Comparisons • View Profitability Comparisons • View Management Effectiveness

Customers Net Income fell by AMGN's customers Net margin fell to %
-4.58 % 3.41 %
• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers
You need to upgrade your Flash Player

You need to upgrade your Flash Player

You need to upgrade your Flash Player
Major Competitors Stock performance

5 Days Decrease / Increase
ABBV        2.32% 
BIIB   -1.46%    
AGN   -0.03%    
JNJ   -1.17%    
BMY        1.5% 
MRK   -0.08%    
• View Complete Report


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

QMCI's Profile

Stock Price

QMCI's Financials

Business Description


Charts & Quotes

QMCI's News


QMCI's Competitors

Customers & Markets

Economic Indicators

QMCI's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength



Management Effectivness


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071